Biopharmaceutics applications in drug development

Por Krishna, Rajesh., Yu, Lawrence.
Publicado em 2008

Evaluation of USP apparatus 3 for dissolution testing of immediate-release products

Por Yu, Lawrence X., Wang, Jin T., Hussain, Ajaz S.
Publicado em 2002

Batch-to-Batch Quality Consistency Evaluation of Botanical Drug Products Using Multivariate Statistical Analysis of the Chromatographic Fingerprint

Por Xiong, Haoshu, Yu, Lawrence X., Qu, Haibin
Publicado em 2013

Impact of Osmotically Active Excipients on Bioavailability and Bioequivalence of BCS Class III Drugs

Por Chen, Mei-Ling, Sadrieh, Nakissa, Yu, Lawrence
Publicado em 2013

Chronically Implanted Pressure Sensors: Challenges and State of the Field

Por Yu, Lawrence, Kim, Brian J., Meng, Ellis
Publicado no Sensors (Basel) (2014)

A case of orf disease in a patient with scleroderma

Por Maor, Danit, Yu, Lawrence L., Brand, Roland
Publicado no JAAD Case Rep (2017)

Mechanistic Approaches to Predicting Oral Drug Absorption

Por Huang, Weili, Lee, Sau Lawrence, Yu, Lawrence X.
Publicado em 2009

Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products

Por Chang, Rong-Kun, Raw, Andre, Lionberger, Robert, Yu, Lawrence
Publicado em 2012

Generic Development of Topical Dermatologic Products, Part II: Quality by Design for Topical Semisolid Products

Por Chang, Rong-Kun, Raw, Andre, Lionberger, Robert, Yu, Lawrence
Publicado em 2013

Erratum to: Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products

Por Chang, Rong-Kun, Raw, Andre, Lionberger, Robert, Yu, Lawrence
Publicado no AAPS J (2015)

Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development

Por Zhang, Xinyuan, Lionberger, Robert A., Davit, Barbara M., Yu, Lawrence X.
Publicado em 2011

Dissolution Testing for Generic Drugs: An FDA Perspective

Por Anand, Om, Yu, Lawrence X., Conner, Dale P., Davit, Barbara M.
Publicado em 2011

Application of Quality by Design to the Process Development of Botanical Drug Products: A Case Study

Por Zhang, Lei, Yan, Binjun, Gong, Xingchu, Yu, Lawrence X., Qu, Haibin
Publicado em 2013

International Guidelines for Bioequivalence of Systemically Available Orally Administered Generic Drug Products: A Survey of Similarities and Differences

Por Davit, Barbara, Braddy, April C., Conner, Dale P., Yu, Lawrence X.
Publicado em 2013

Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugs

Por Yu, Lawrence X., Ellison, Christopher D., Conner, Dale P., Lesko, Larry J., Hussain, Ajaz S.
Publicado em 2001

Quality by Design: Concepts for ANDAs

Por Lionberger, Robert A., Lee, Sau Lawrence, Lee, LaiMing, Raw, Andre, Yu, Lawrence X.
Publicado em 2008

A multiple biomarker assay for quality assessment of botanical drugs using a versatile microfluidic chip

Por Li, Zhen-Hao, Ai, Ni, Yu, Lawrence X., Qian, Zhong-Zhi, Cheng, Yi-Yu
Publicado no Sci Rep (2017)

FDA’s new pharmaceutical quality initiative: Knowledge-aided assessment & structured applications

Por Yu, Lawrence X., Raw, Andre, Wu, Larisa, Capacci-Daniel, Christina, Zhang, Ying, Rosencrance, Susan
Publicado no Int J Pharm X (2019)

Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation

Por Zou, Peng, Yu, Yanke, Zheng, Nan, Yang, Yongsheng, Paholak, Hayley J., Yu, Lawrence X., Sun, Duxin
Publicado em 2012

Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs

Por Haidar, Sam H., Makhlouf, Fairouz, Schuirmann, Donald J., Hyslop, Terry, Davit, Barbara, Conner, Dale, Yu, Lawrence X.
Publicado em 2008